搜尋
產品
社群
市場
新聞
經紀商
更多
TW
立即開始
Crispr is here to stay
看多
Editas Medicine, Inc.
(
NASDAQ:EDIT
)
active023
已更新
NASDAQ:EDIT
Editas Medicine, Inc.
Trend Analysis
3
0
trendanalysis
Looks like a lot studies are reporting positive news, I think there is going to rally within crispr stocks.
交易結束:目標達成:
Seems like we have had reached the target earlier than expected. I would recommend to take partial profit here.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款
閱讀更多資訊。